Five details:
1. For the year, the company generated $8.62 million in revenue, a 7 percent decrease year over year.
2. While seeing a dip in revenue, SpineGuard sold 9,001 DSG systems. This is up 3 percent compared to the 8,764 sold in 2017.
3. SpineGuard sold 5,336 systems in the U.S., representing 59 percent of total units sold. This was also up 1 percent compared to the 5,303 units sold in the U.S. in 2017.
4. For the fourth quarter, SpineGuard recorded $2.36 million in revenue, a 5 percent decrease year-over-year.
5. SpineGuard will release its next financial report March 14. The company expects full-year net income for its U.S. operations to be positive for the first time in 2018.
More articles on devices and implants:
Nextech acquires EMR solution for orthopedic practices: 3 details
How China-US tariff tension affects orthopedic companies; Moody’s thinks they’ll adapt
3 things to know about AxioMed
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
